The largest database of trusted experimental protocols

Hotstart taq

Manufactured by Qiagen
Sourced in Germany

HotStart Taq is a heat-activated DNA polymerase enzyme used for PCR (Polymerase Chain Reaction) amplification of DNA. It is designed to remain inactive at lower temperatures, preventing non-specific amplification, and becomes active only at higher temperatures during the PCR process.

Automatically generated - may contain errors

18 protocols using hotstart taq

1

Quantifying DNA Methylation in T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from T cells using a QIAmp DNA isolation kit (Qiagen Inc., Valencia, CA). All samples were analyzed in a blinded fashion using the EpigenDx custom pyrosequencing service (EpigenDx, Inc., Hopkinton, MA). Briefly, bisulfite treatment of 2 μg of DNA was carried out using the EZ DNA methylation kit (Zymo Research, Orange, CA) according to manufacturer’s instructions. Hot-start PCR was carried out with HotStart Taq (Qiagen Inc.) using 100 ng of bisulfite treated DNA. PCR and pyrosequencing primers are shown in Table 1. Direct quantification of the ratio of unmethylated to methylated cytosines was determined for each site using Pyro Q-CpG software. The IFNG non-CpG cytosine at site -181 bp served as an internal control and revealed that bisulfite conversion of DNA was greater than 95%. Likewise, only slight variability was detected in DNA samples treated with bisulfite on different days. The naïve NK92 cell line demonstrated complete conversion following bisulfite treatment and served as a demethylation control.
+ Open protocol
+ Expand
2

Transient Transfection of CHO-lec Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO-lec cells were transiently transfected with each of the four constructs and the CD62L mRNA was quantified by qRT-PCR. β-actin was used as a control. CHO-lec cells were grown in 6 well plates in DMEM to approximately 50% confluent. Transfection media consisted of a mixture of 2 mL of serum-free Opti-MEM, 6 μL of PEI, and 2 μg of either RSA, IgG, native 1, or native 2 leader constructs and was incubated for 20 minutes at room temperature before adding to the CHO-lec cells. After 3 days at 37 °C, total mRNA was isolated using a Qiagen RNeasy Mini Kit. First-strand cDNA was synthesized using the Invitrogen SuperScript III reverse transcriptase kit, followed by PCR reaction using Hot Start Taq from Qiagen. Primers used were: CD62L forward 5′-GAACAAGGAGGACTGCGTGGAGA-3′, CD62L reverse 5′-CTTTAGTTTGTGGCAGGCGTCATC-3′, β-actin forward 5′-CCAAGGCCAACCGTGAAAAGAT-3′, and β-actin reverse 5′-CGACCAGAGGCATACAGGCACAG-3′. A 30-cycle PCR was carried out at 98 °C for 15 minutes, 98 °C for 30 seconds, 50 °C for 30 seconds, 72 °C for 1 minute, repeating steps 2–4 30 times, 72 °C for 2.5 minutes, 4 °C hold.
+ Open protocol
+ Expand
3

Capillary Sequencing of BRAF Mutations in Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Capillary sequencing was performed as previously described [29 (link)–31 (link)]. Briefly, we amplified tumor DNA in a 15 μl PCR containing approximately 40 ng of purified genomic DNA in a mixture of 1.5 μl of Buffer (10x), 1.5 μl dNTP (2 mM), 0.08 μl Qiagen HotStart Taq (5U/μl) and 2 μl forward and reverse primer (5 mM). After denaturation at 95°C for 15 minutes, 35 amplification cycles at 95°C for 40s, 60°C for 30s, 72°C for 50s followed by elongation at 72°C for 10 minutes were performed.
Sequencing was conducted with Big Dye Terminator sequencing kit v1.1 (Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions, and sequencing reactions were electrophoresed on an ABI 3130xl genetic analyzer (Applied Biosystems, Carlsbad, CA, USA). Sequencing reactions were repeated at least twice by independent PCR, with forward and reverse primers, and the sample was scored as being mutated when the mutation was observed both times. BRAF primers for amplification of exon 15, used for both PCR and Capillary sequencing were previously described [31 (link)].
+ Open protocol
+ Expand
4

Serovar-specific PCR Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
We did not succeed in combining the serotyping PCRs described by Jia et al. [13 (link)] as a multiplex PCR, neither by increasing the concentration of MgCl2 nor by adding 3% DMSO (NEB, Frankfurt, Germany) or 5 × Q-solution (Qiagen, Hilden, Germany). Individual serovar monoplex-PCRs were carried out with Qiagen HotStart Taq as described above. Final concentrations for primers were: for serovar 2—0.5 µM, for serovar 8, 9, 13, 15—1 µM, and for the serovars 1, 4, 6, 7, 10, 11, 14—2 µM. Only the PCR identifying serovar 5 and 12, respectively, was run as a duplex PCR with a final concentration of 0.2 µM for each of the serovar 12 primers and 1.2 µM for each of the serovar 5/12 primers. Annealing temperatures were chosen as listed by Jia et al. for the different primers and held for 90 s. 35 cycles were run. All other reaction components and cycling parameters were the same as described above.
+ Open protocol
+ Expand
5

Genetic Manipulation and Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mutation and plasmid constructions were performed as previously described.9 (link) DNA was prepared and purified using a commercial kit (Qiagen). Oligonucleotides were synthesized by Integrated DNA Technologies Inc. Restriction endonucleases and ligase were purchased from New England Biolabs. HotStart® Taq (Qiagen) was used for routine PCR. FastStartH High fidelity PCR system (Roche) was used for construction of plasmids. All cloning products were verified by DNA sequencing. Site direct mutagenesis was accomplished with a site-directed mutagenesis kit (QuikChange®). Expression of fipB and mutant genes was verified by Western blot with rabbit anti-FipB antibody.9 (link) DNA transformation was performed as previously described.4 (link)
+ Open protocol
+ Expand
6

Pyrosequencing of Bisulfite-Treated DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Templates used for pyrosequencing were prepared by bisulfite modified DNA. Each PCR was performed in a 40ul volume containing 0.6ul of each primer, 4ul 10XPCR buffer, 0.5ul QIAGEN hotstart Taq, 31.5ul distilled water, and 2.0ul template DNA (treated by bisulfite, EpiTect Bisulfite Kit, Qiagen). Reactions were incubated at 95°C for 3 min, followed by 50 amplification cycles (95°C for 15s, 54°C for 30s, 72°C for 30s), and then a final elongation step at 72°C for 5 min, with the temperature then held at 4°C. Amplicons were confirmed by agarose gel electrophoresis and purified using a QIAquick Gel Extraction Kit (Qiagen ). After mixed with 40ul sequencing buffer (contained 0.5uM sequencing primer), degeneration was performed at 80°C for 2 min. Pyrosequencing was performed using PyroMark ID sequencer.
Primer used in prosequencing.
Cg05163709 Forward: GGAAAGGGGTGATTAAATATTTAGTTA
Reverse: 5′-BIOTIN-CAACCTAATAAAAAACTATACAAACACAT
Sequencing primer: ATAAGTATGTTTAATTATTGTTTAAG
Cg27539833 Forward: GGAATAGTTTAGTTAAAGAAAAAGGTTAAGAT
Reverse: 5′-BIOTIN-AATTTACCACAATACACAAAAAACTAACTACTTA
Sequencing primer: AGATTTTAGTAGTTTTTTGTCGTTA
+ Open protocol
+ Expand
7

RNA Extraction and Quantitative RT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was prepared using the TRI Reagent (Molecular Research Center, Cincinnati, OH) in accordance with the manufacturer’s instructions as previously described [14 (link)]. Briefly, cDNA was synthesized from 2 μg of total RNA using ImProm-II reverse transcriptase (Promega, Madison, WI) and amplified by RT-PCR using HotStart Taq (Qiagen, Valencia, CA) and gene-specific primers. 18S ribosomal RNA was used as an internal RT-PCR control. For quantitative real-time RT-PCR (qRT-PCR), cDNAs were amplified using Premix Ex Taq (TaKaRa, Tokyo, Japan), SYBR Green I (Molecular Probes, Eugene, OR), and a Step One Plus system (Applied Biosystems, Foster City, CA).
+ Open protocol
+ Expand
8

ChIP-qPCR Protocol for Histone Modifications

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with Fugene HD (Promega Corporation). After 48 h, ChIP was performed according to the X-ChIP protocol (Abcam) with minor modifications. Briefly, after cell harvesting, 250-μl cell lysates were sonicated as for primary neurons and checked by electrophoresis to give mainly small fragments of 300–500 bp. Lysates were immuno-precipitated with 2-μg mouse anti-HA antibodies (Sigma, H3663) overnight, followed by adding 20-μl DiaMag protein A-coated magnetic beads for 2 h. The complex was washed three times with IP buffer, once with low salt wash buffer and once with TE plus 50-mM NaCl. DNA was eluted and purified according to X-ChIP protocol. Input (3.5%) was used for comparison. DNA fragments were detected by PCR using Hotstart Taq (Qiagen) with specific primers. The sequences of ChIP Primers (5′ → 3′) were:
GBX2-F (TGCTAACTGCAGGATGGAGC) and GBX2-R (CTTGGAGACTCGAGGAAGCC); PRSS16-F (ATGAATCTGTTGGGCTGCGA) and PRSS16-R (TGGGTTTGCTTCCAGTACCC); BDNF-F (GCATTCAGTGGCTGCTTCAAGG) and BDNF-R (GGGCTGCAATGAACAGAGGTC); GRIN2A-F (GCTTAGAAGTGGCAGCCTCA) and GRIN2A-R(AATGCTTCTCCCTGTGCCTC); ACTB-F (GCGCCGCTGGGTTTTATAGG) and ACTB-R (CTCCTCTTCCTCAATCTCGCTC).
+ Open protocol
+ Expand
9

Validation of Genetic Variants by PCR and Sanger Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Variants that were significant by case–control analysis were validated by polymerase chain reaction (PCR) and Sanger sequencing. PCR primer sets were designed using Primer-BLAST [40 (link)]. DNA amplification by PCR was performed using HotStartTaq (Qiagen, Venlo, Netherlands) or Q5 High-Fidelity (New England Biolabs, Ipswich, MA, USA) DNA polymerase, as described in the manufacturer’s protocol. Primer sequences and their respective cycling conditions are listed in Additional file 4: Table S5. The PCR products were then analyzed by 2% agarose gel electrophoresis and purified with ExoSAP-IT Express (Thermo Scientific, USA) prior to sequencing. Cycle sequencing reactions were performed using BigDye Terminator v3.1 kit (Applied Biosystems, Foster City, CA) and the sequencing products were analyzed on a Genetic Analyzer. DNA sequences were visualized and aligned using Geneious Prime version 2022.1.
+ Open protocol
+ Expand
10

Microsatellite Genotyping of Mosquitoes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microsatellite markers were chosen to span the entire genome [17 (link), 43 (link)]. Mosquitoes were collected from six countries (Obuasi, Ghana: N = 45, Pahou, Benin: N = 48, Lagdo, Cameroon: N = 48, Tororo, Uganda: N = 48) with two collection time points in Chikwawa, Malawi (2010: N = 48, 2002: N = 48) and Chokwe (2009: N = 48) and Morrumbene (2002: N = 45) Mozambique. 17 microsatellites (both di- and tri-nucleotide repeats) were amplified from genomic DNA using 1.5 μl of reaction Buffer, 0.2 μl of dNTP mix (25 mmol), 0.325 μl of both the forward (included a 19bp tag) and reverse primers, 0.2 μl of Hot Start Taq (Qiagen Inc.), 1 μl of MgCl2 and 1μl of genomic DNA (15ng/ul). Forward and reverse primers are listed in S1 Table. PCR thermocycler conditions were: 5min at 95°C followed by 35 cycles of denaturing at 94°C for 30s, annealing at 58°C for 30s and extension at 72°C for 30s, finishing with an extension step at 72°C for 10min. Fragment sizing was carried out using a Beckman Coulter CEQ8000. Fragment sizes were visualized and recorded using the fragment analysis software on the Beckman Coulter CEQ8000. Micro-Checker version 2.2.3 [44 ] was used to check for null allele and scoring errors.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!